YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis makes offer to buy German cancer drugmaker

Posted online

Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.

Novartis is offering $73 per share, a premium of around 142%.

Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.

Read more from Quartz.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences